AaronLeeDO(He/Him)

Oncology • Aurora, CO

Hematology/Oncology Fellow, University of Colorado Anschutz Medical Campus

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
1655 Aurora Ct Anschutz Cancer Pavilion
Aurora, CO 80045

Summary

Hematology/Oncology Fellow at University of Colorado, with special interests in Solid Tumors, medical education, Quality Improvement/Patient Experience, and academic medicine. Former Chief Resident in Quality and Safety at UC San Diego Internal Medicine Residency

Education & Training

University of ColoradoFellowship, Hematology and Medical Oncology, 2023 - 2026
University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 2022 - 2023
University of California (San Diego) Medical CenterResidency, Internal Medicine, 2019 - 2022
College of Osteopathic Medicine of the PacificClass of 2019, D.O.
UC San Diego M.S., Biology , 2012 - 2014
UC San Diego B.S., Molecular biology , 2009 - 2013

Certifications & Licensure

CA State License 2022 - 2024
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case series.
Elizabeth U Tran, Eric Royz, Kyra Yamamoto, Samantha Marley, Alexander Song
The Prostate. 2025-01-01
4 citations
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer.
Aaron M Lee, Ava Saidian, Justin Shaya, Taylor Nonato, Angelo Cabal
Clinical Genitourinary Cancer. 2022-12-01
1 citations
Age-Adjusted Schedules of Venetoclax and Hypomethylating Agents to Treat Extremely Elderly Patients with Acute Myeloid Leukemia.
Aaron M Lee, Aaron M Goodman, James K Mangan
Case Reports in Hematology. 2022-01-01

Press Mentions

Case Series Suggests Venetoclax Plus Hypomethylating Agent Therapy Tolerable, Effective in Very Elderly AML PatientsJuly 4th, 2022

Grant Support

Center for Empathy and Compassion Training in Medical Education: Seed Grant ProgramT. Denny Sanford Institute for Empathy and Compassion UC San Diego2022–2023